Medical Malpractice Rx Act

Stem Cell Research: advocated that current National Institutes of Health guidelines governing stem cell research remain in effect, allowing federally funded research on human pluripotent stem cells to proceed; PL104-191, Health Insurance Portability and Accountability Act: advocated through formal comment process to seek changes and modifications in proposed medical privacy rules mandated by the Health Insurance Portability and Accountability Act. Specifically, addressed regulatory scheme related to research as complex and burdensome and requested modifications in regulations on charitable contributions; S.721, Nursing Employment and Education Development Act (NEED Act):advocated for passage of bill; S.1864/HR 3487, Nurse Reinvestment Act: advocated for support and passage of bills which provide scholarship funds, public awareness and education campaigns; Labor, HHS, Education FY 2002 Appropriations bill:advocated support for continued funding for research facilities construction through the NIH's National Center for Resources Research. Supported funding in President's request of $100 million for FY 2002: advocated support for increased funding for the health professions of $440 million for programs provided under Title VII and VIII in FY 2002 Labor, HHS, Education Appropriations bill;advocated support for maintaining the NIH salary cap at Executive Level I ($161,200), within the context of the FY 2002 Labor, HHS, Education Appropriations bill; HR 2178, All-Payer Graduate Medical Education Act of 2001; monitored house bill which would establish an all-payer trust fund to support Graduate Medical Education: monitored legislation in the House and Senate which would provide health care coverage for the uninsured. Congress' FY 2002 budget outline has set aside funds to address the issue of the uninsured, while Hopkins will monitor and gauge impact of proposed legislation; monitored Senate bill (Kennedy-Frist) and House bill (DeGette-Greenwood) which would increase protection of participants in human subject research. Working with Department of Health and Human Services and the Office of Human Research Protection to re-review protocols, on-going research, etc.;Contacted Maryland Senators and House Member to seek their assistance in delaying the suspension of federally supported medical research projects, involving human subjects, at the Johns Hopkins Institutions; Contacted the Office of the Secretary of Health and Human Services seeking assistance with the Office of Human Research Protection (OHRP) to delay the suspension of all federally supported medical research projects at the Johns Hopkins Institutions; S. 543, Mental Health Equitable Treatment Act of 2001; monitored and gauged impact of bill which would provide for equal coverage of mental health benefits with respect to health insurance coverage; HR 2103, Medical Malpractice RX Act; monitored and gauged impact of bill which would establish limits on medical malpractice claims, and for other purposes.

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), President of the U.S., SENATE

H.R. 2103 - "Medical Malpractice Rx Act" Legislation to establish limits on medical malpractice claims, and for other purposes. H.R. 3448, S. 1715 S. 1765, S. Amdt. 2692- "Bioterrorism Preparedness Act of 2001" Legislation to improve the ability of the United States to prevent, prepare for, and respond to bioterrorism and other public health emergencies. H.R. 3160 - "Bioterrorism Prevention Act of 2001" Legislation to amend the Antiterrorism and Effective Death Penalty Act of 1996 with respect to the responsibilities of the Secretary of Health and Human Services regarding biological agents and toxins, and to amend title 18, United States Code, with respect to such agents and toxins. S. 1635 - "Pathogen Research, Emergency Preparedness and Response Efforts Act of 2001” Legislation to ensure the prompt research, development, manufacture, and distribution of new life-saving drugs, biologics, and medical devices that prevent or mitigate the consequences of a chemical or biological bioterrorist attack, and for other purposes. U.S. Department of Health and Human Services, Office of the Secretary, 45 CFR Parts 160 and 164 - Standards for Privacy of Individually Identifiable Information; Final Rule. S. 590 - " Relief, Equity, Access, and Coverage for Health (REACH) Act" Legislation to amend the Internal Revenue Code of 1986 to allow a refundable tax credit for health insurance costs, and for other purposes. S. 283 - " Bipartisan Patient Protection Act of 2001" Legislation to amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue code of 1986 to protect consumers in managed care plans and other health coverage. S. 284 - " Bipartisan Patient Protection Act of 2001-Part II" Legislation to amend the Internal Revenue Code of 1986 to provide incentives to expand health care coverage for individuals. S. 889 - " Bipartisan Patients' Bill of Rights Act of 2001" Legislation to protect consumers in managed care plans and in other health coverage. S. 872, H.R. 526 -"Patients' Bill of Rights Bill" Legislation to amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to protect consumers in managed care plans and other health coverage. H.R. 2315 - "Patients' Bill of Rights Act of 2001" Legislation to protect consumers in managed care plans and in other health coverage. Regulation of clinical trials/human subject protection.

Stem Cell Research: advocated that current National Institutes of Health guidelines governing stem cell research remain in effect, allowing federally funded research on human pluripotent stem cells to proceed; PL104-191, Health Insurance Portability and Accountability Act: advocated through formal comment process to seek changes and modifications in proposed medical privacy rules mandated by the Health Insurance Portability and Accountability Act. Specifically, addressed regulatory scheme related to research as complex and burdensome and requested modifications in regulations on charitable contributions; S.721, Nursing Employment and Education Development Act (NEED Act):advocated for passage of bill; S.1864/HR 3487, Nurse Reinvestment Act: advocated for support and passage of bills which provide scholarship funds, public awareness and education campaigns; Labor, HHS, Education FY 2002 Appropriations bill:advocated support for continued funding for research facilities construction through the NIH's National Center for Resources Research. Supported funding in President's request of $100 million for FY 2002: advocated support for increased funding for the health professions of $440 million for programs provided under Title VII and VIII in FY 2002 Labor, HHS, Education Appropriations bill;advocated support for maintaining the NIH salary cap at Executive Level I ($161,200), within the context of the FY 2002 Labor, HHS, Education Appropriations bill; HR 2178, All-Payer Graduate Medical Education Act of 2001; monitored house bill which would establish an all-payer trust fund to support Graduate Medical Education: monitored legislation in the House and Senate which would provide health care coverage for the uninsured. Congress' FY 2002 budget outline has set aside funds to address the issue of the uninsured, while Hopkins will monitor and gauge impact of proposed legislation; monitored Senate bill (Kennedy-Frist) and House bill (DeGette-Greenwood) which would increase protection of participants in human subject research. Working with Department of Health and Human Services and the Office of Human Research Protection to re-review protocols, on-going research, etc.;Contacted Maryland Senators and House Member to seek their assistance in delaying the suspension of federally supported medical research projects, involving human subjects, at the Johns Hopkins Institutions; Contacted the Office of the Secretary of Health and Human Services seeking assistance with the Office of Human Research Protection (OHRP) to delay the suspension of all federally supported medical research projects at the Johns Hopkins Institutions; S. 543, Mental Health Equitable Treatment Act of 2001; monitored and gauged impact of bill which would provide for equal coverage of mental health benefits with respect to health insurance coverage; HR 2103, Medical Malpractice RX Act; monitored and gauged impact of bill which would establish limits on medical malpractice claims, and for other purposes.

H.R. 1639 - Common Sense Medical Malpractice Reform Act of 2001 H.R. 2103 - Medical Malpractice Rx Act H.R. 2315 - CARE Act of 2001

Client expense: $2,932,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of the Comptroller of the Currency (OCC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)

Stem Cell Research: advocated that current National Institutes of Health guidelines governing stem cell research remain in effect, allowing federally funded research on human pluripotent stem cells to proceed; PL104-191, Health Insurance Portability and Accountability Act: advocated through formal comment process to seek changes and modifications in proposed medical privacy rules mandated by the Health Insurance Portability and Accountability Act. Specifically, addressed regulatory scheme related to research as complex and burdensome and requested modifications in regulations on charitable contributions; S.721, Nursing Employment and Education Development Act (NEED Act):advocated for passage of bill; S.1864/HR 3487, Nurse Reinvestment Act: advocated for support and passage of bills which provide scholarship funds, public awareness and education campaigns; Labor, HHS, Education FY 2002 Appropriations bill:advocated support for continued funding for research facilities construction through the NIH's National Center for Resources Research. Supported funding in President's request of $100 million for FY 2002: advocated support for increased funding for the health professions of $440 million for programs provided under Title VII and VIII in FY 2002 Labor, HHS, Education Appropriations bill;advocated support for maintaining the NIH salary cap at Executive Level I ($161,200), within the context of the FY 2002 Labor, HHS, Education Appropriations bill; HR 2178, All-Payer Graduate Medical Education Act of 2001; monitored house bill which would establish an all-payer trust fund to support Graduate Medical Education: monitored legislation in the House and Senate which would provide health care coverage for the uninsured. Congress' FY 2002 budget outline has set aside funds to address the issue of the uninsured, while Hopkins will monitor and gauge impact of proposed legislation; monitored Senate bill (Kennedy-Frist) and House bill (DeGette-Greenwood) which would increase protection of participants in human subject research. Working with Department of Health and Human Services and the Office of Human Research Protection to re-review protocols, on-going research, etc.;S. 543, Mental Health Equitable Treatment Act of 2001; monitored and gauged impact of bill which would provide for equal coverage of mental health benefits with respect to health insurance coverage; HR 2103, Medical Malpractice RX Act; monitored and gauged impact of bill which would establish limits on medical malpractice claims, and for other purposes.

H.R. 1639 Common Sense Medical Malpractice Reform Act of 2001 H.R. 2103 - Medical Malpractice Rx Act H.R. 2315 - CARE Act of 2001

Client expense: $1,520,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of the Comptroller of the Currency (OCC), SENATE, State, Dept of (DOS), Treasury, Dept of

PL 105-115 - Food and Drug Modernization Act of 1997. (Improvements to FDA regulatory process for medical devices. Oversight activities conducted to monitor process of FDA in implementing legislative provisions. S. 1052, S. 872, S. 283 - Bipartisan Patient Protection Act of 2001 S. 889 - Bipartisan Patients' Bill of Rights Act of 2001 H.R. 2315 - Patients' Bill of Rights Act of 2001 H.R. 526 - Bipartisan Patient Protection Act of 2001 (To protect consumers in managed care plans and other health coverage.) S. 700 and S. 708 - Animal Disease Risk Assessment, Prevention, and Control Act of 2001 (For the purpose of coordinating actions to prevent the outbreak of bovine spngiform encephalopath (commonly known as "mad cow disease" and foot-and-mouth disease) in the United States.) H.R. 2103 - Medical Malpractice Rx Act (To establish limits on medical malpractice claims, and for other purposes.) S. 824 - Medication Errors Reduction Act of 2001 (To establish informatics grant program for hospitals and skilled nursing facilities.)

Client expense: $2,220,000 · Firm income: Not reported